BOCA RATON, Fla., Oct. 23, 2019 /PRNewswire/ -- Celsius Holdings, Inc. (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced that the company has significantly expanded the total number of retail locations. CELSIUS® is available, as trend forward functional energy brands capitalize on consumer shifts towards healthier, bet

COLUMBIA, S.C. and TAMPA, Fla., Oct. 23, 2019 /PRNewswire/ -- WellCare of South Carolina, a WellCare Health Plans, Inc. (NYSE: WCG) company, announced it is offering its WellCare Medicare Advantage members expanded access to the top health systems across the state.

HANGZHOU, China, Oct. 23, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced that the Company hosted a reception for Mr. Jiangyong Zhou, Member of

TOREKOV, Sweden, Oct. 23, 2019 /PRNewswire/ -- Nolato AB has today published its interim report for the third quarter of 2019.Sales totalled SEK 1,980 million (1,980) Operating profit (EBITA) rose to SEK 238 million (SEK 222 million excl. a ne

LAS VEGAS, Oct. 23, 2019 /PRNewswire/ -- Breast Cancer Awareness Month may be winding down, but Patricia Levett's battle against metastatic breast cancer continues. This week, the 48-year-old grandmother from Clayton, North Carolina, will embark on her 27th Miracle Flight

LYNBROOK, N.Y., Oct. 23, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, tod

REDWOOD SHORES, Calif., Oct. 23, 2019 /PRNewswire/ -- Oracle Health Sciences, a leader in eClinical technology and Phlexglobal, pioneers in the provision of Trial Master File (TMF) technology and services for the global life sciences industry, have announced enhanced integrations to accelerate the speed and accuracy of regulatory compliance and inspection readiness in clinical trials.

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2019 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced it has entered into a strategic collaboration and license agreement with Novartis covering the development and commercialization of P

BRIDGEWATER, N.J., Oct. 23, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its third quarter 2019 financial results on Wednesday, October 30, 2019.Ins

VANCOUVER, Oct. 23, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has signed a non-binding letter of intent (the "LOI") to acquire all of the outstanding shares of 1210950 B.C. Ltd. dba Rainy Daze Cannabis Corp. ("Rain